Search research articles
Contact Us
Filters
Showing results (61-70 of 103) with videos related to
Page
of 11
Sort By:
Investigational New Drugs
|
September 22, 2012
Phase I and pharmacokinetic study of IV vinflunine in cancer patients with liver dysfunction
J P Delord, A Ravaud, J Bennouna, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
August 28, 2002
Prognostic factors of survival and rapid progression in 782 patients with metastatic renal carcinomas treated by cytokines: a report from the Groupe Français d'Immunothérapie
S Négrier, B Escudier, F Gomez, et al.
Journal De Chirurgie
|
June 1, 1992
[Treatment of cancer of the kidney with interleukin 2 in adults, the Lyon experience]
S Negrier, A Mercatello, B Coronel, et al.
Presse Medicale (Paris, France : 1983)
|
June 28, 1986
[Gallbladder collapse in drug-induced hepatitis]
P Cales, J Perpere, J Trocard, et al.
European Radiology
|
February 28, 2013
Ten-year experience of percutaneous image-guided radiofrequency ablation of malignant renal tumours in high-risk patients
P Balageas, F Cornelis, Y Le Bras, et al.
Gut
|
November 1, 1990
Incidence of large oesophageal varices in patients with cirrhosis: application to prophylaxis of first bleeding
P Calès, H Desmorat, J P Vinel, et al.
The Journal of Urology
|
May 19, 2009
Sequential sorafenib and sunitinib for renal cell carcinoma
M P Sablin, S Negrier, A Ravaud, et al.
British Journal of Cancer
|
November 27, 2001
Granulocyte-macrophage colony-stimulating factor alone or with dacarbazine in metastatic melanoma: a randomized phase II trial
A Ravaud, M Delaunay, C Chevreau, et al.
British Journal of Cancer
|
February 1, 1995
A phase I trial of repeated tumour-infiltrating lymphocyte (TIL) infusion in metastatic melanoma
A Ravaud, E Legrand, M M Delaunay, et al.
European Journal of Cancer (Oxford, England : 1990)
|
August 31, 2001
UFT and leucovorin in first-line chemotherapy for patients with metastatic gastric cancer. An Early Clinical Studies Group (ECSG)/European Organization for Research Treatment of Cancer (EORTC) phase II trial
A Ravaud, M Borner, J H Schellens, et al.
Page
of 11
Search research articles
Search
Showing results (61-70 of 103) with videos related to
Sort By:
Page
of 11
Investigational New Drugs
|
September 22, 2012
Phase I and pharmacokinetic study of IV vinflunine in cancer patients with liver dysfunction
J P Delord, A Ravaud, J Bennouna, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
August 28, 2002
Prognostic factors of survival and rapid progression in 782 patients with metastatic renal carcinomas treated by cytokines: a report from the Groupe Français d'Immunothérapie
S Négrier, B Escudier, F Gomez, et al.
Journal De Chirurgie
|
June 1, 1992
[Treatment of cancer of the kidney with interleukin 2 in adults, the Lyon experience]
S Negrier, A Mercatello, B Coronel, et al.
Presse Medicale (Paris, France : 1983)
|
June 28, 1986
[Gallbladder collapse in drug-induced hepatitis]
P Cales, J Perpere, J Trocard, et al.
European Radiology
|
February 28, 2013
Ten-year experience of percutaneous image-guided radiofrequency ablation of malignant renal tumours in high-risk patients
P Balageas, F Cornelis, Y Le Bras, et al.
Gut
|
November 1, 1990
Incidence of large oesophageal varices in patients with cirrhosis: application to prophylaxis of first bleeding
P Calès, H Desmorat, J P Vinel, et al.
The Journal of Urology
|
May 19, 2009
Sequential sorafenib and sunitinib for renal cell carcinoma
M P Sablin, S Negrier, A Ravaud, et al.
British Journal of Cancer
|
November 27, 2001
Granulocyte-macrophage colony-stimulating factor alone or with dacarbazine in metastatic melanoma: a randomized phase II trial
A Ravaud, M Delaunay, C Chevreau, et al.
British Journal of Cancer
|
February 1, 1995
A phase I trial of repeated tumour-infiltrating lymphocyte (TIL) infusion in metastatic melanoma
A Ravaud, E Legrand, M M Delaunay, et al.
European Journal of Cancer (Oxford, England : 1990)
|
August 31, 2001
UFT and leucovorin in first-line chemotherapy for patients with metastatic gastric cancer. An Early Clinical Studies Group (ECSG)/European Organization for Research Treatment of Cancer (EORTC) phase II trial
A Ravaud, M Borner, J H Schellens, et al.
Page
of 11